MovDisordV3, PascalFrancis, Curation, bibRecord, 001A11

Executive Dysfunction Using Behavioral Assessment of the Dysexecutive Syndrome in Parkinson's Disease

Identifieur interne : 001A11 ( PascalFrancis/Curation ); précédent : 001A10; suivant : 001A12

Executive Dysfunction Using Behavioral Assessment of the Dysexecutive Syndrome in Parkinson's Disease

Auteurs : Satoshi Kamei [Japon] ; Motohiko Hara [Japon] ; Kan Serizawa [Japon] ; Masato Murakami [Japon] ; Tomohiko Mizutani [Japon] ; Motoko Ishiburo [Japon] ; Ritsuko Kawahara [Japon] ; Yukiko Takagi [Japon] ; Katsuhiko Ogawa [Japon] ; Hirokazu Yoshihashi [Japon] ; Satoru Shinbo [Japon] ; Yutaka Suzuki [Japon] ; Mai Yamaguchi [Japon] ; Akihiko Morita [Japon] ; Jun Takeshita [Japon] ; Kaname Hirayanagi [Japon]

Source :

Movement disorders [ 0885-3185 ] ; 2008.

RBID : Pascal:08-0199303

Descripteurs français

Pascal (Inist)
- Trouble cognitif, Maladie de Parkinson, Pathologie du système nerveux, Fonction exécutive, Facteur risque, Echelle d'évaluation.

English descriptors

KwdEn :
- Cognitive disorder, Evaluation scale, Executive function, Nervous system diseases, Parkinson disease, Risk factor.

Abstract

The objective of this study was to evaluate the executive dysfunction (ExD) in Parkinson's disease (PD) using the Behavioral Assessment of the Dysexecutive Syndrome (BADS), which provides a wide-range assessment of ExD. The BADS and the Unified Parkinson's Disease Rating Scale (UPDRS) were investigated in 63 nondemented PD patients who revealed scores of ≥24 points on the Mini-Mental State Examination based on the DSM-IV. Multiple logistic regression analysis was performed to evaluate the predisposing factors to ExD, which was defined as <70 points on the age-controlled standardized score. The total score on the UPDRS was a significant independent predisposing factor to ExD. Among the various parts of the UPDRS, part II was the significant factor for ExD. The profile scores of all subtests on the BADS in patients with ExD were significantly lower than those of patients without ExD. All profile scores decreased with severity of PD, but the changes among these scores differed. ExD in nondemented PD predisposed to a greater severity of PD, particularly as regards the activity of daily living impairment. Nondemented PD revealed wide-range components of ExD. All components of ExD were impaired with severity of PD, but the patterns of each component exhibited variety.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 23`
A06				`@2 4`
A08	`01`	`1`	`ENG`	`@1 Executive Dysfunction Using Behavioral Assessment of the Dysexecutive Syndrome in Parkinson's Disease`
A11	`01`	`1`		`@1 KAMEI (Satoshi)`
A11	`02`	`1`		`@1 HARA (Motohiko)`
A11	`03`	`1`		`@1 SERIZAWA (Kan)`
A11	`04`	`1`		`@1 MURAKAMI (Masato)`
A11	`05`	`1`		`@1 MIZUTANI (Tomohiko)`
A11	`06`	`1`		`@1 ISHIBURO (Motoko)`
A11	`07`	`1`		`@1 KAWAHARA (Ritsuko)`
A11	`08`	`1`		`@1 TAKAGI (Yukiko)`
A11	`09`	`1`		`@1 OGAWA (Katsuhiko)`
A11	`10`	`1`		`@1 YOSHIHASHI (Hirokazu)`
A11	`11`	`1`		`@1 SHINBO (Satoru)`
A11	`12`	`1`		`@1 SUZUKI (Yutaka)`
A11	`13`	`1`		`@1 YAMAGUCHI (Mai)`
A11	`14`	`1`		`@1 MORITA (Akihiko)`
A11	`15`	`1`		`@1 TAKESHITA (Jun)`
A11	`16`	`1`		`@1 HIRAYANAGI (Kaname)`
A14	`01`			`@1 Division of Neurology, Department of Medicine, Nihon University School of Medicine @2 Tokyo @3 JPN @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 5 aut. @Z 9 aut. @Z 10 aut. @Z 11 aut. @Z 12 aut. @Z 13 aut. @Z 14 aut. @Z 15 aut.`
A14	`02`			`@1 Clinic of Psychosomatic Medicine, Nihon University Itabashi Hospital @2 Tokyo @3 JPN @Z 4 aut. @Z 6 aut. @Z 7 aut. @Z 8 aut.`
A14	`03`			`@1 Department of Hygiene and Public Health, Nihon University of Physical Education @2 Tokyo @3 JPN @Z 16 aut.`
A20				`@1 566-573`
A21				`@1 2008`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000183361080120`
A44				`@0 0000 @1 © 2008 INIST-CNRS. All rights reserved.`
A45				`@0 30 ref.`
A47	`01`	`1`		`@0 08-0199303`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 The objective of this study was to evaluate the executive dysfunction (ExD) in Parkinson's disease (PD) using the Behavioral Assessment of the Dysexecutive Syndrome (BADS), which provides a wide-range assessment of ExD. The BADS and the Unified Parkinson's Disease Rating Scale (UPDRS) were investigated in 63 nondemented PD patients who revealed scores of ≥24 points on the Mini-Mental State Examination based on the DSM-IV. Multiple logistic regression analysis was performed to evaluate the predisposing factors to ExD, which was defined as <70 points on the age-controlled standardized score. The total score on the UPDRS was a significant independent predisposing factor to ExD. Among the various parts of the UPDRS, part II was the significant factor for ExD. The profile scores of all subtests on the BADS in patients with ExD were significantly lower than those of patients without ExD. All profile scores decreased with severity of PD, but the changes among these scores differed. ExD in nondemented PD predisposed to a greater severity of PD, particularly as regards the activity of daily living impairment. Nondemented PD revealed wide-range components of ExD. All components of ExD were impaired with severity of PD, but the patterns of each component exhibited variety.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Trouble cognitif @5 01`
C03	`01`	`X`	`ENG`	`@0 Cognitive disorder @5 01`
C03	`01`	`X`	`SPA`	`@0 Trastorno cognitivo @5 01`
C03	`02`	`X`	`FRE`	`@0 Maladie de Parkinson @2 NM @5 02`
C03	`02`	`X`	`ENG`	`@0 Parkinson disease @2 NM @5 02`
C03	`02`	`X`	`SPA`	`@0 Parkinson enfermedad @2 NM @5 02`
C03	`03`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 03`
C03	`03`	`X`	`ENG`	`@0 Nervous system diseases @5 03`
C03	`03`	`X`	`SPA`	`@0 Sistema nervioso patología @5 03`
C03	`04`	`X`	`FRE`	`@0 Fonction exécutive @5 09`
C03	`04`	`X`	`ENG`	`@0 Executive function @5 09`
C03	`04`	`X`	`SPA`	`@0 Función ejecutiva @5 09`
C03	`05`	`X`	`FRE`	`@0 Facteur risque @5 10`
C03	`05`	`X`	`ENG`	`@0 Risk factor @5 10`
C03	`05`	`X`	`SPA`	`@0 Factor riesgo @5 10`
C03	`06`	`X`	`FRE`	`@0 Echelle d'évaluation @5 11`
C03	`06`	`X`	`ENG`	`@0 Evaluation scale @5 11`
C03	`06`	`X`	`SPA`	`@0 Escala evaluación @5 11`
C07	`01`	`X`	`FRE`	`@0 Pathologie de l'encéphale @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Syndrome extrapyramidal @5 38`
C07	`02`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`03`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`04`	`X`	`FRE`	`@0 Pathologie du système nerveux central @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
N21				`@1 126`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001308

Links to Exploration step

Pascal:08-0199303

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Executive Dysfunction Using Behavioral Assessment of the Dysexecutive Syndrome in Parkinson's Disease</title>
<author><name sortKey="Kamei, Satoshi" sort="Kamei, Satoshi" uniqKey="Kamei S" first="Satoshi" last="Kamei">Satoshi Kamei</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Hara, Motohiko" sort="Hara, Motohiko" uniqKey="Hara M" first="Motohiko" last="Hara">Motohiko Hara</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Serizawa, Kan" sort="Serizawa, Kan" uniqKey="Serizawa K" first="Kan" last="Serizawa">Kan Serizawa</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Murakami, Masato" sort="Murakami, Masato" uniqKey="Murakami M" first="Masato" last="Murakami">Masato Murakami</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinic of Psychosomatic Medicine, Nihon University Itabashi Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Mizutani, Tomohiko" sort="Mizutani, Tomohiko" uniqKey="Mizutani T" first="Tomohiko" last="Mizutani">Tomohiko Mizutani</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Ishiburo, Motoko" sort="Ishiburo, Motoko" uniqKey="Ishiburo M" first="Motoko" last="Ishiburo">Motoko Ishiburo</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinic of Psychosomatic Medicine, Nihon University Itabashi Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Kawahara, Ritsuko" sort="Kawahara, Ritsuko" uniqKey="Kawahara R" first="Ritsuko" last="Kawahara">Ritsuko Kawahara</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinic of Psychosomatic Medicine, Nihon University Itabashi Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Takagi, Yukiko" sort="Takagi, Yukiko" uniqKey="Takagi Y" first="Yukiko" last="Takagi">Yukiko Takagi</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinic of Psychosomatic Medicine, Nihon University Itabashi Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Ogawa, Katsuhiko" sort="Ogawa, Katsuhiko" uniqKey="Ogawa K" first="Katsuhiko" last="Ogawa">Katsuhiko Ogawa</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Yoshihashi, Hirokazu" sort="Yoshihashi, Hirokazu" uniqKey="Yoshihashi H" first="Hirokazu" last="Yoshihashi">Hirokazu Yoshihashi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Shinbo, Satoru" sort="Shinbo, Satoru" uniqKey="Shinbo S" first="Satoru" last="Shinbo">Satoru Shinbo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Suzuki, Yutaka" sort="Suzuki, Yutaka" uniqKey="Suzuki Y" first="Yutaka" last="Suzuki">Yutaka Suzuki</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Yamaguchi, Mai" sort="Yamaguchi, Mai" uniqKey="Yamaguchi M" first="Mai" last="Yamaguchi">Mai Yamaguchi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Morita, Akihiko" sort="Morita, Akihiko" uniqKey="Morita A" first="Akihiko" last="Morita">Akihiko Morita</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Takeshita, Jun" sort="Takeshita, Jun" uniqKey="Takeshita J" first="Jun" last="Takeshita">Jun Takeshita</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Hirayanagi, Kaname" sort="Hirayanagi, Kaname" uniqKey="Hirayanagi K" first="Kaname" last="Hirayanagi">Kaname Hirayanagi</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Hygiene and Public Health, Nihon University of Physical Education</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0199303</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0199303 INIST</idno>
<idno type="RBID">Pascal:08-0199303</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001308</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001A11</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Executive Dysfunction Using Behavioral Assessment of the Dysexecutive Syndrome in Parkinson's Disease</title>
<author><name sortKey="Kamei, Satoshi" sort="Kamei, Satoshi" uniqKey="Kamei S" first="Satoshi" last="Kamei">Satoshi Kamei</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Hara, Motohiko" sort="Hara, Motohiko" uniqKey="Hara M" first="Motohiko" last="Hara">Motohiko Hara</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Serizawa, Kan" sort="Serizawa, Kan" uniqKey="Serizawa K" first="Kan" last="Serizawa">Kan Serizawa</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Murakami, Masato" sort="Murakami, Masato" uniqKey="Murakami M" first="Masato" last="Murakami">Masato Murakami</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinic of Psychosomatic Medicine, Nihon University Itabashi Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Mizutani, Tomohiko" sort="Mizutani, Tomohiko" uniqKey="Mizutani T" first="Tomohiko" last="Mizutani">Tomohiko Mizutani</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Ishiburo, Motoko" sort="Ishiburo, Motoko" uniqKey="Ishiburo M" first="Motoko" last="Ishiburo">Motoko Ishiburo</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinic of Psychosomatic Medicine, Nihon University Itabashi Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Kawahara, Ritsuko" sort="Kawahara, Ritsuko" uniqKey="Kawahara R" first="Ritsuko" last="Kawahara">Ritsuko Kawahara</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinic of Psychosomatic Medicine, Nihon University Itabashi Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Takagi, Yukiko" sort="Takagi, Yukiko" uniqKey="Takagi Y" first="Yukiko" last="Takagi">Yukiko Takagi</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinic of Psychosomatic Medicine, Nihon University Itabashi Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Ogawa, Katsuhiko" sort="Ogawa, Katsuhiko" uniqKey="Ogawa K" first="Katsuhiko" last="Ogawa">Katsuhiko Ogawa</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Yoshihashi, Hirokazu" sort="Yoshihashi, Hirokazu" uniqKey="Yoshihashi H" first="Hirokazu" last="Yoshihashi">Hirokazu Yoshihashi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Shinbo, Satoru" sort="Shinbo, Satoru" uniqKey="Shinbo S" first="Satoru" last="Shinbo">Satoru Shinbo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Suzuki, Yutaka" sort="Suzuki, Yutaka" uniqKey="Suzuki Y" first="Yutaka" last="Suzuki">Yutaka Suzuki</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Yamaguchi, Mai" sort="Yamaguchi, Mai" uniqKey="Yamaguchi M" first="Mai" last="Yamaguchi">Mai Yamaguchi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Morita, Akihiko" sort="Morita, Akihiko" uniqKey="Morita A" first="Akihiko" last="Morita">Akihiko Morita</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Takeshita, Jun" sort="Takeshita, Jun" uniqKey="Takeshita J" first="Jun" last="Takeshita">Jun Takeshita</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Hirayanagi, Kaname" sort="Hirayanagi, Kaname" uniqKey="Hirayanagi K" first="Kaname" last="Hirayanagi">Kaname Hirayanagi</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Hygiene and Public Health, Nihon University of Physical Education</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cognitive disorder</term>
<term>Evaluation scale</term>
<term>Executive function</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Risk factor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Trouble cognitif</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du   système nerveux</term>
<term>Fonction exécutive</term>
<term>Facteur risque</term>
<term>Echelle d'évaluation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The objective of this study was to evaluate the executive dysfunction (ExD) in Parkinson's disease (PD) using the Behavioral Assessment of the Dysexecutive Syndrome (BADS), which provides a wide-range assessment of ExD. The BADS and the Unified Parkinson's Disease Rating Scale (UPDRS) were investigated in 63 nondemented PD patients who revealed scores of ≥24 points on the Mini-Mental State Examination based on the DSM-IV. Multiple logistic regression analysis was performed to evaluate the predisposing factors to ExD, which was defined as <70 points on the age-controlled standardized score. The total score on the UPDRS was a significant independent predisposing factor to ExD. Among the various parts of the UPDRS, part II was the significant factor for ExD. The profile scores of all subtests on the BADS in patients with ExD were significantly lower than those of patients without ExD. All profile scores decreased with severity of PD, but the changes among these scores differed. ExD in nondemented PD predisposed to a greater severity of PD, particularly as regards the activity of daily living impairment. Nondemented PD revealed wide-range components of ExD. All components of ExD were impaired with severity of PD, but the patterns of each component exhibited variety.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>23</s2>
</fA05>
<fA06><s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Executive Dysfunction Using Behavioral Assessment of the Dysexecutive Syndrome in Parkinson's Disease</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>KAMEI (Satoshi)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>HARA (Motohiko)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SERIZAWA (Kan)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>MURAKAMI (Masato)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>MIZUTANI (Tomohiko)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>ISHIBURO (Motoko)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>KAWAHARA (Ritsuko)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>TAKAGI (Yukiko)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>OGAWA (Katsuhiko)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>YOSHIHASHI (Hirokazu)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>SHINBO (Satoru)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>SUZUKI (Yutaka)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>YAMAGUCHI (Mai)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>MORITA (Akihiko)</s1>
</fA11>
<fA11 i1="15" i2="1"><s1>TAKESHITA (Jun)</s1>
</fA11>
<fA11 i1="16" i2="1"><s1>HIRAYANAGI (Kaname)</s1>
</fA11>
<fA14 i1="01"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
<sZ>13 aut.</sZ>
<sZ>14 aut.</sZ>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Clinic of Psychosomatic Medicine, Nihon University Itabashi Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Hygiene and Public Health, Nihon University of Physical Education</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>16 aut.</sZ>
</fA14>
<fA20><s1>566-573</s1>
</fA20>
<fA21><s1>2008</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000183361080120</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2008 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>30 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>08-0199303</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The objective of this study was to evaluate the executive dysfunction (ExD) in Parkinson's disease (PD) using the Behavioral Assessment of the Dysexecutive Syndrome (BADS), which provides a wide-range assessment of ExD. The BADS and the Unified Parkinson's Disease Rating Scale (UPDRS) were investigated in 63 nondemented PD patients who revealed scores of ≥24 points on the Mini-Mental State Examination based on the DSM-IV. Multiple logistic regression analysis was performed to evaluate the predisposing factors to ExD, which was defined as <70 points on the age-controlled standardized score. The total score on the UPDRS was a significant independent predisposing factor to ExD. Among the various parts of the UPDRS, part II was the significant factor for ExD. The profile scores of all subtests on the BADS in patients with ExD were significantly lower than those of patients without ExD. All profile scores decreased with severity of PD, but the changes among these scores differed. ExD in nondemented PD predisposed to a greater severity of PD, particularly as regards the activity of daily living impairment. Nondemented PD revealed wide-range components of ExD. All components of ExD were impaired with severity of PD, but the patterns of each component exhibited variety.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Trouble cognitif</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Cognitive disorder</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Trastorno cognitivo</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Fonction exécutive</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Executive function</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Función ejecutiva</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Facteur risque</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Risk factor</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Factor riesgo</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Echelle d'évaluation</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Evaluation scale</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Escala evaluación</s0>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du   système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21><s1>126</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A11 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001A11 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:08-0199303
   |texte=   Executive Dysfunction Using Behavioral Assessment of the Dysexecutive Syndrome in Parkinson's Disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Executive Dysfunction Using Behavioral Assessment of the Dysexecutive Syndrome in Parkinson's Disease

Executive Dysfunction Using Behavioral Assessment of the Dysexecutive Syndrome in Parkinson's Disease

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri